Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four people worldwide. Once called non-alcoholic fatty liver disease, this condition ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...

Research revealed that medications widely used for diabetes and obesity may offer significant benefits for patients with ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The findings on the Ayurvedic treatment of liver cirrhosis have been formally recognized in the scientific community, with ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.